References
- Lamprea-Montealegre JA, Astor BC, McClelland R, et al. LDL Phenotype-B is strongly associated with CHD risk among individuals with CKD. The Multi-ethnic Study of Atherosclerosis (MESA). Circulation. 2013;128:A9258.
- Damman K, Lambers-Heerspink HJ. Are renin–angiotensin–aldosterone system inhibitors lifesaving in chronic kidney disease? J Am Coll Cardiol. 2014;63:659–660.
- Selnes OA, Gottesman RF, Grega MA, Baumgartner WA, Zeger SL, McKhann GM. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med. 2012;366:250–257.
- Chung CP, Oeser A, Solus JF, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196:756–763.
- Montalescot G, Sechtem U, Achenbach S, et al. Corrigendum to:‘2013 ESC guidelines on the management of stable coronary artery disease’. Eur Heart J. 2014;35:2260–2261.
- De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve–guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208–1217.
- Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail. 2009;31:910–919.
- Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis. 2010;55:452–462.
- Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: Implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008;191:376–382.
- Ten Dam M, Wetzels J. Toxicity of contrast media: An update. Neth J Med. 2008;66:416–422.
- Seeliger E, Sendeski M, Rihal CS, Persson PB. Contrast-induced kidney injury: Mechanisms, risk factors, and prevention. Eur Heart J. 2012;33:2007–2015.
- Bashore TM, Bates ER, Berger PB, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:2170–2214.
- Liistro F, Falsini G, Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J. 2003;4:668–676.
- Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264.
- Nikolsky E, Aymong ED, Dangas G, Mehran R. Radiocontrast nephropathy: Identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med. 2002;4:S7–S14.
- Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780–1785.
- Baek SD, Jang S-J, Park S-E, et al. Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin. J Korean Med Sci. 2011;26:1634–1637.
- Desir GV. Role of renalase in the regulation of blood pressure and the renal dopamine system. Curr Opin Nephrol Hypertens. 2011;20:31–36.
- Maioli M, Toso A, Leoncini M, Micheletti C, Bellandi F. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: A randomized, controlled trial. Circ Cardiovasc Interv. 2011;4:456–462.
- Haase M, Haase-Fielitz A, Bellomo R, et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: A pilot double-blind, randomized controlled trial. Crit Care Med. 2009;37:39–47.
- Sandbaek A, Griffin SJ, Rutten G, et al. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk: The ADDITION study. Diabetologia. 2008;51:1127–1134.